BioWorld4d
Maze Therapeutics discovers SLC6A19 inhibitors
Maze Therapeutics Inc. has disclosed new sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, metabolic syndrome, ...
Labiotech.eu4d
A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations
Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
Haber Gazetesi4d
How the World's Best Clinics Achieve Success in Parkinson's Treatment
The world's best clinics achieve success in Parkinson’s treatment by individualizing deep brain stimulation (DBS) through ...
Denali Therapeutics: Vast Pipeline, First Approval Up Ahead
Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...
Frontiers20d
Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder
Proteins were extracted using 500 ul RIPA buffer (150 mM NaCl, 50 mM Tris, 1% v/v NP-40, 0.5% deoxycholic acid, and 0.1% w/v SDS, pH 7.4) containing protease inhibitors (Roche Applied Science, United ...
C&EN26d
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor
Department of Drug Chemistry and Technologies, Sapienza University of Rome, P.le Aldo Moro 5, Rome 00185, Italy ...
C&EN27d
Synthesis, Pharmacological Evaluation, and Molecular Modeling of Phthalimide Derivatives as Monoamine Oxidase and Cholinesterase Dual Inhibitors
Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan ...